Super Session 5

New era in CNS: Rising from the ashes

30 November 2023

09:00 - 10:00 Auditorium 10-11
New era in CNS: Rising from the ashes

Super Session 5

09:00 - 10:00 Auditorium 10-11

Diseases in the central nervous system are devastating for patients and their families and costly for society. Pharma and biotech companies from the Nordics have been actively involved in the recent developments of treatment of Alzheimer’s diseases and other neurological disorders. This session highlights the recent successes in the field of CNS and explores the key factors to advance treatments of CNS diseases.

Moderator(s): Dr. Marc-Olivier Bévierre - Life Science Practice Leader, Vintura

Speaker(s):

Dr. Richard Reschen - Director, Business Development & Licensing , MSD
Dr. Gunilla Osswald - CEO, BioArctic
Dr. Peter Horn Møller - Founder & Partner, Marigold Innovation

full program